Literature DB >> 11458305

The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.

P D Harvey1, M R Serper, L White, M J Parrella, S R McGurk, P J Moriarty, C Bowie, N Vadhan, J Friedman, K L Davis.   

Abstract

This study examined the relationship between clinical rating of cognitive symptoms and performance on neuropsychological tests in acute and chronic samples of patients with schizophrenia. Two separate studies examined patients who varied widely in their lifetime functional outcome, including 263 elderly poor-outcome inpatients and 20 acutely admitted patients. In the first study, six cognitive performance measures were collected, and in the second study, five different measures were collected. Correlations with different symptom models of cognitive and negative symptoms were examined. In both samples, cognitive symptoms were never more highly correlated with cognitive test performance than with negative symptoms. When cognitive and negative symptom ratings were combined, they never accounted for as much as half of the variance in performance on the cognitive tests in both samples. These data suggest that clinical assessment of symptoms is not a viable alternative to neuropsychological testing to obtain information about cognitive functioning in schizophrenia. These results may also be specific to the clinical rating scale used, the Positive and Negative Syndrome Scale (PANSS). Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11458305     DOI: 10.1053/comp.2001.24587a

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  13 in total

1.  A meta-analysis of cognitive remediation in schizophrenia.

Authors:  Susan R McGurk; Elizabeth W Twamley; David I Sitzer; Gregory J McHugo; Kim T Mueser
Journal:  Am J Psychiatry       Date:  2007-12       Impact factor: 18.112

2.  Effects of Δ-THC on Working Memory: Implications for Schizophrenia?

Authors:  Nehal P Vadhan; Mark R Serper; Margaret Haney
Journal:  Prim psychiatry       Date:  2009-01-01

3.  Is it possible to assess cognitive impairment other than with neuropsychological tests?

Authors:  Philip D Harvey
Journal:  Psychiatry (Edgmont)       Date:  2009-01

4.  The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements.

Authors:  Philip D Harvey; Michael F Green; Christopher Bowie; Antony Loebel
Journal:  Psychopharmacology (Berl)       Date:  2006-06-17       Impact factor: 4.530

Review 5.  Negative symptoms and cognitive deficits: what is the nature of their relationship?

Authors:  Philip D Harvey; Danny Koren; Abraham Reichenberg; Christopher R Bowie
Journal:  Schizophr Bull       Date:  2005-10-12       Impact factor: 9.306

6.  Should cognitive impairment be included in the diagnostic criteria for schizophrenia?

Authors:  Richard S E Keefe
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

Review 7.  How should DSM-V criteria for schizophrenia include cognitive impairment?

Authors:  Richard S E Keefe; Wayne S Fenton
Journal:  Schizophr Bull       Date:  2007-06-13       Impact factor: 9.306

Review 8.  Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

9.  Insight into neurocognitive dysfunction in schizophrenia.

Authors:  Alice Medalia; Julie Thysen
Journal:  Schizophr Bull       Date:  2008-01-16       Impact factor: 9.306

10.  Metacognitive awareness of cognitive problems in schizophrenia: exploring the role of symptoms and self-esteem.

Authors:  M Cella; S Swan; E Medin; C Reeder; T Wykes
Journal:  Psychol Med       Date:  2013-06-05       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.